Vaccines

Value Communications

Access comprehensive, tailored communication solutions

Personalized vaccine communication strategy

Access our wide range of value communication solutions, tailored to your vaccine, and designed to deliver commercial success.

Alira Health’s in-house team works closely with you to create a detailed, personalized communication strategy that outlines the differentiating factors of your vaccine.
Our multidisciplinary, industry-leading approach includes:
  • Developing payer value propositions and value dossiers
  • Identifying indication-specific opportunities related to epidemiological situation and burden of disease
  • Highlighting specific value (e.g., MoA, clinical benefit, epidemiology)
  • Defining competitive access positioning in different patient groups, age groups, and market segments
  • Demonstrating robust economic and societal value
  • Developing communication tools to support vaccine uptake

Why choose Alira Health?

As our partner, you’ll benefit from our:

  • Focused attention on your specific needs, individual aspects of your vaccine, and corporate communication strategy
  • In-house industry experts with over 25 years of experience working with the key market stakeholders—from payers to doctors
  • In-depth knowledge and understanding of local and global market dynamics and and communication channels

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Bernd Schollmeier
Bernd Shollmier
Vice President of Global Market Access Vaccines
We are seeing a lot of traction in the industry, as well as interest in vaccine production. To support companies in a challenging payer environment, we created a dedicated vaccine division in our Global Market Access department to provide a variety of solutions that maximize patient access and the gross-to-net value of the product across the full product lifecycle.

Related News

News September 8, 2023
Alira Health Partners With Col·legi de Metges de Barcelona
We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.
Market Access Spain Startups
News August 31, 2023
Alira Health Named One of the World’s Best Management Consulting Firms by Forbes
Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.
Life Sciences MedTech Pharma
Events August 10, 2023
12th EPP Life Sciences Pricing Forum
We are excited to speak at the 12th EPP Life Sciences Pricing Forum for pricing directors and executives in Life Sciences.
EU Market Access
Events July 31, 2023
LSI Europe Emerging MedTech Summit
We will attend LSI Europe Emerging MedTech Summit in Barcelona to discuss the latest advancements, challenges, and trends in the industry.
MedTech Spain
Events July 31, 2023
ESMO Congress
We are excited to join the ESMO Congress in Madrid. to disseminate the latest cutting-edge data for oncologists and other stakeholders.
Drug Development Market Access Oncology Spain
Publications July 25, 2023
Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets
Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries.
Market Access Pharma
News July 20, 2023
Diabetes Management Devices Market Trends 2023 is Released
Alira Health announced today the publication of the Diabetes Management Devices Market Trends 2023, in collaboration with MassMEDIC, the Massachusetts Medical Device Industry Council.
Diabetes MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.